Bohring-Opitz (Oberklaid-Danks) Syndrome: Clinical study, review of the literature, and discussion of possible pathogenesis

Rob Hastings, Jan Maarten Cobben, Gabriele Gillessen-Kaesbach, Judith Goodship, Hanne Hove, Susanne Kjaergaard, Helena Kemp, Helen Kingston, Peter Lunt, Sahar Mansour, Ruth McGowan, Kay Metcalfe, Catherine Murdoch-Davis, Mary Ray, Marlène Rio, Sarah Smithson, John Tolmie, Peter Turnpenny, Bregje Van Bon, Dagmar WieczorekRuth Newbury-Ecob*

*Corresponding author for this work
20 Citations (Scopus)

Abstract

Bohring-Opitz syndrome (BOS) is a rare congenital disorder of unknown etiology diagnosed on the basis of distinctive clinical features. We suggest diagnostic criteria for this condition, describe ten previously unreported patients, and update the natural history of four previously reported patients. This is the largest series reported to date, providing a unique opportunity to document the key clinical features and course through childhood. Investigations undertaken to try and elucidate the underlying pathogenesis of BOS using array comparative genomic hybridization and tandem mass spectrometry of cholesterol precursors did not show any pathogenic changes responsible.

Original languageEnglish
JournalEuropean Journal of Human Genetics
Volume19
Issue number5
Pages (from-to)513-519
Number of pages7
ISSN1018-4813
DOIs
Publication statusPublished - 01.05.2011

Fingerprint

Dive into the research topics of 'Bohring-Opitz (Oberklaid-Danks) Syndrome: Clinical study, review of the literature, and discussion of possible pathogenesis'. Together they form a unique fingerprint.

Cite this